Lupin currently produces more than 180 affordable generic medications and is the 3rd largest pharmaceutical company in the U.S. in terms of prescriptions dispensed. Lupin’s generic business is steadfastly committed to quality and reliability, which ensures the consistent delivery of high-quality products to the market.
| Product Name | Strength | Image (not to scale) | Pack Size | NDC # | RLD / Brand Name | TE Rating | Therapeutic Category |
|---|---|---|---|---|---|---|---|
| Ganirelix Acetate Injection | 250mcg/0.5mL |
 |
(1) 250mcg single-dose pre-filled syringe |
70748-274-01 |
Ganirelix Acetate Injection |
AP |
Competitive gonadotropin-releasing hormone antagonist (GnRH antagonist) |
| GaviLAX (PEG3350) Powder for Oral Solution | 17gm/scoopful |
|
238g |
43386-312-14 |
MiraLAX® |
AA |
Laxative |
| GaviLyte™ – C | 240 -5.84-2.98-6.72-22.72gm |
 |
4 L |
43386-060-19 |
Colyte® |
AA |
Hyperosmotic |
| GaviLyte™ – G | 236-5.86-2.97-6.74-22.74 gm |
|
4 L |
43386-090-19 |
GoLYTELY® |
AA |
Hyperosmotic |
*All registered trademarks are the property of their respective owners. These products are intended for U.S. residents only.
Information provided on this site is intended for use only by residents of United States. The products discussed herein are available only upon prescription from a medical doctor or qualified medical professional. Consumers should not construe any information herein as medical advice or as a substitute for discussions with a prescribing practitioner or other qualified medical professional. Reader understand and agrees to the foregoing.
